Company registration number: 11748997
Unaudited financial statements
for the year ended 31 March 2025
for
Clinical Pharmacist Solutions Ltd
Pages for filing with the Registrar
Company registration number: 11748997
Clinical Pharmacist Solutions Ltd
Balance sheet
as at 31 March 2025
31 Mar 25 31 Mar 24
Note £ £ £ £
Fixed assets
Tangible assets 4 26,060 31,442
26,060 31,442
Current assets
Debtors 1,200,905 639,262
Cash at bank and in hand 5,413 361,120
1,206,318 1,000,382
Creditors: amounts falling due within one
year 		(523,816) (601,172)
Net current assets 682,502 399,210
Total assets less current liabilities 708,562 430,652
Creditors: Amounts falling due after more
than one year 		(89,900) -
NET ASSETS 618,662 430,652
Capital and reserves
Called up share capital 2 2
Share premium account 21,000 21,000
Profit and loss account 597,660 409,650
TOTAL EQUITY 618,662 430,652
The company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies for the year ended 31 March 2025.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges their responsibilities to comply with the Companies Act 2006 in respect to accounting records and the preparation of financial statements.
1
Company registration number: 11748997
Clinical Pharmacist Solutions Ltd
Balance sheet - continued
as at 31 March 2025
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
In accordance with Section 444 of the Companies Act 2006, the Profit and loss account has not been delivered to the Registrar.
Signed by:
Mr M Mamayusupov, Director
30 December 2025
2
Clinical Pharmacist Solutions Ltd
Notes to the financial statements
for the year ended 31 March 2025
1 Company information
Clinical Pharmacist Solutions Ltd is a private company registered in England and Wales. Its registered number is 11748997. The company is limited by shares. Its registered office is Fergusson House, 124 City Road, London, EC1V 2NX.
2 Accounting policies
Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” including the provisions of Section 1A “Small Entities” and the Companies Act 2006. The financial statements have been prepared under the historic cost convention.
Presentation currency
The company's financial statements are presented in sterling.
Going concern
In preparing these financial statements, the director has assessed whether there are any material uncertainties related to events or conditions that cast significant doubt upon the company's ability to continue as a going concern. In making this assessment, the director takes into account all available information about the future which is at least 12 months from the date that the financial statements are authorised for issue.
The director considers that the company has adequate resources to continue in business for the foreseeable future and that it is appropriate to adopt the going concern basis in preparing the financial statements.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, Value Added Tax and other sales taxes.
Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Plant and machinery etc.:
Fixtures & fittings - 20% straight line
Computer equipment - 20% straight line
3
Clinical Pharmacist Solutions Ltd
Notes to the financial statements - continued
for the year ended 31 March 2025
2 Accounting policies - continued
Taxation
Taxation for the year comprises current taxation. Tax is recognised in the Profit and loss account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.
Current taxation assets and liabilities are not discounted.
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.
Retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit and loss in the period to which they relate.
3 Average number of employees
During the year the average number of employees was 50 (2024 - 49).
4 Tangible fixed assets
Plant and
machinery
etc.
£
Cost
At 1 April 2024 46,835
Additions 5,098
At 31 March 2025 51,933
Depreciation
At 1 April 2024 15,393
Charge for year 10,480
At 31 March 2025 25,873
Net book value
At 31 March 2025 26,060
At 31 March 2024 31,442
4
Clinical Pharmacist Solutions Ltd
Notes to the financial statements - continued
for the year ended 31 March 2025
5 Advances, credit and guarantees granted to the director
The following advances and credits to a director subsisted during the periods ended 31 March 2025 and 31 March 2024.
31 Mar 25 31 Mar 24
£ £
Mahmud Mamayusupov
Amounts advanced 784,432 -
Amounts repaid (124,000) -
Balance outstanding at end of year 660,432 -
The loan was provided for the purpose of a property purchase, is unsecured, and is repayable on demand. Interest is charged on the outstanding balance at a rate of 2.25% per annum, payable annually.
5